Abstract
Dupuytren's disease (DD) is a superficial fibromatosis of the hand. Although the molecular mechanisms responsible for this disease are unknown, recent studies suggest that beta-catenin may be a key factor involved in fibromatosis. In this study, we analysed the in vivo and in vitro expression levels of beta-catenin in DD, using surgical specimens and primary cell lines. Although no somatic mutations (exon 3) of beta-catenin were detected, Western blot analysis revealed high levels of beta-catenin in diseased palmar fascia, and low to undetectable levels of beta-catenin in patient-matched normal palmar fascia. Immunohistochemistry analysis showed high levels of beta-catenin expression within the disease fascia, as well as cytoplasmic and nuclear accumulations of the protein. Immunoprecipitation of beta-catenin from seven patient lesions showed the protein to be tyrosine phosphorylated. Lastly, Western analysis of three patient-matched (disease and normal fascia) primary cell cultures showed significantly elevated levels of beta-catenin in disease cells cultured in three-dimensional collagen lattices. This is the first extensive in vivo and in vitro characterization of beta-catenin in DD, and the first to suggest that the extracellular matrix may play an important role in modulating beta-catenin stability in DD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM and Wu TT . (2002). Hum. Pathol., 33, 39–46.
An HS, Southworth SR, Jackson WT and Russ B . (1988). J. Hand Surg. Am., 13, 872–874.
Arafa M, Noble J, Royle SG, Trail IA and Allen J . (1992). J. Hand Surg. Br., 17, 221–224.
Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier W . (1993). J. Cell. Biol., 120, 757–766.
Bonnici AV, Birjandi F, Spencer JD, Fox SP and Berry AC . (1992). J. Hand Surg. Br., 17, 349–355.
Boudreau N and Bissell MJ . (1998). Curr. Opin. Cell. Biol., 10, 640–646.
Burge P . (1999). Hand Clin., 15, 63–71.
Burge P, Hoy G, Regan P and Milne R . (1997). J. Bone Joint Surg. Br., 79, 206–210.
Cadigan KM and Nusse R . (1997). Genes Dev., 11, 3286–3305.
Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H and Alman BA . (2002). Proc. Natl. Acad. Sci. USA, 30, 30.
Dal Cin P, De Smet L, Sciot R, Van Damme B and Van den Berghe H . (1999). Cancer Genet. Cytogenet., 108, 137–140.
De Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R and Willen H . (2000). Mod. Pathol., 13, 1080–1085.
Dupuytren G . (1834). Lancet, 2, 222–225.
Gradl D, Kuhl M and Wedlich D . (1999). Mol. Cell. Biol., 19, 5576–5587.
Gudmundsson KG, Arngrimsson R, Sigfusson N and Jonsson T . (2002). J. Clin. Epidemiol., 55, 5–10.
Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R and Sukhatme VP . (2002a). J. Biol. Chem., 277, 16464–16469.
Hanai J, Gloy J, Karumanchi SA, Kale S, Tang J, Hu G, Chan B, Ramchandran R, Jha V, Sukhatme VP and Sokol S . (2002b). J. Cell. Biol., 158, 529–539.
Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R and Polakis P . (1999). Curr. Biol., 9, 207–210.
Kloen P . (1999). Br. J. Plast. Surg., 52, 629–635.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H . (1997). Science, 275, 1784–1787.
Kuhn MA, Wang X, Payne WG, Ko F and Robson MC . (2002). J. Surg. Res., 103, 146–152.
Latres E, Chiaur DS and Pagano M . (1999). Oncogene, 18, 849–854.
McFarlane RM . (1991). J. Hand Surg. Am., 16, 775–779.
Mikkelsen OA . (1978). Hand, 10, 1–8.
Mikkelsen OA, Hoyeraal HM and Sandvik L . (1999). J. Hand Surg. Br., 24, 515–518.
Montgomery E, Lee JH, Abraham SC and Wu TT . (2001). Mod. Pathol., 14, 695–701.
Morin PJ . (1999). Bioessays, 21, 1021–1030.
Muller T, Choidas A, Reichmann E and Ullrich A . (1999). J. Biol. Chem., 274, 10173–10183.
Noble J, Arafa M, Royle SG, McGeorge G and Crank S . (1992). J. Hand Surg. Br., 17, 71–74.
Noble J, Heathcote JG and Cohen H . (1984). J. Bone Joint Surg. Br., 66, 322–325.
Polakis P . (2000). Genes Dev., 14, 1837–1851.
Rayan GM . (1999). Hand Clin., 15, 87–96, vii.
Ross DC . (1999). Hand Clin., 15, 53–62, vi.
Schwartz MA and Ginsberg MH . (2002). Nat. Cell Biol., 4, E65–E68.
Sergovich FR, Botz JS and McFarlane RM . (1983). N. Engl. J. Med., 308, 162–163.
Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M and Ito F . (1994). Cell Adhes. Commun., 1, 295–305.
Shibata T, Ochiai A, Kanai Y, Akimoto S, Gotoh M, Yasui N, Machinami R and Hirohashi S . (1996). Oncogene, 13, 883–889.
Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM and Kitajewski J . (1997). Cell Growth Differ., 8, 1349–1358.
Skoog T . (1960). Plastic Reconstr. Surg., 31, 258–263.
Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ and Alman BA . (1999). Oncogene, 18, 6615–6620.
Wang H and Chakrabarty S . (2001). J. Cell Physiol., 187, 188–195.
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ and Harper JW . (1999). Genes Dev., 13, 270–283.
Wurster-Hill DH, Brown F, Park JP and Gibson SH . (1988). Am. J. Hum. Genet., 43, 285–292.
Acknowledgements
We thank Roy Taylor and Jeanette Botz from the tissue bank (Department of Pathology, London Health Science Centre) for the paraffin sectioning and immunohistochemistry work. This study is supported by grants from the Plastic Surgery Education Fund (BSG, JCH), Canadian Orthopaedic Foundation (JCH, BSG, DCR, JHR, RMM), American Society for Surgery of the Hand (DCR, JCH, RMM, BSG), and the Lawson Health Research Institute's Internal Research Fund (JCH, BSG).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varallo, V., Gan, B., Seney, S. et al. Beta-catenin expression in Dupuytren's disease: potential role for cell–matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 22, 3680–3684 (2003). https://doi.org/10.1038/sj.onc.1206415
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206415
Keywords
This article is cited by
-
Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease
Gene Therapy (2023)
-
C-X-C domain ligand 14-mediated stromal cell–macrophage interaction as a therapeutic target for hand dermal fibrosis
Communications Biology (2023)
-
Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease
Journal of Cell Communication and Signaling (2016)
-
WT1 expression is increased in primary fibroblasts derived from Dupuytren’s disease tissues
Journal of Cell Communication and Signaling (2015)
-
Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway
Modern Pathology (2010)